Skip to main content
. 2013 Dec;54(12):3293–3302. doi: 10.1194/jlr.M043489

Fig. 4.

Fig. 4.

ABCA1-mediated cholesterol efflux from J774 mouse macrophages treated with cpt-cAMP using WT apoA-I and the apoA-I[225–230] mutant as cholesterol acceptors (A). LCAT activation capacity of WT apoA-I and the apoA-I[225–230] mutant. Experiments were performed as described in Materials and Methods. The data represent the average from two independent experiments performed in triplicate (B).